Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022

NCT07291752 is registered in ClinicalTrials.gov with Suez Canal University as lead sponsor.

NCT NCT07291752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07291752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022
Lead sponsor
Suez Canal University
Phase
Observational
Overall status
Completed
Start date
December 1, 2000
Completion date
December 30, 2022
Enrollment
93,481 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoid tumor, second primary malignant neoplasm